nefazodone has been researched along with Sleep Initiation and Maintenance Disorders in 12 studies
nefazodone: may be useful as an opiate adjunct
Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This paper reports combined results of three identical, multisite, randomized, double-blind, 8-week, acute-phase trials comparing nefazodone (n = 64) with fluoxetine (n = 61) in outpatients with nonpsychotic major depressive disorder and insomnia." | 9.08 | Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. ( Albala, BJ; Armitage, R; Erman, MK; Fleming, JB; Gillin, JC; Kaplita, SB; McQuade, RD; Moldofsky, H; Montplaisir, J; Rush, AJ; Vogel, GW; Winokur, A; Yonkers, KA, 1998) |
| "One hundred sixty-six patients suffering from major depressive disorders were treated for 8 weeks with nefazodone in an open study in dosage ranges from 200 to 600 mg." | 5.08 | Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability. ( Case, WG; DeMartinis, N; Garcia España, FG; Greenblatt, DJ; Mandos, LA; Rickels, K; Schweizer, E, 1998) |
| "This paper reports combined results of three identical, multisite, randomized, double-blind, 8-week, acute-phase trials comparing nefazodone (n = 64) with fluoxetine (n = 61) in outpatients with nonpsychotic major depressive disorder and insomnia." | 5.08 | Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. ( Albala, BJ; Armitage, R; Erman, MK; Fleming, JB; Gillin, JC; Kaplita, SB; McQuade, RD; Moldofsky, H; Montplaisir, J; Rush, AJ; Vogel, GW; Winokur, A; Yonkers, KA, 1998) |
| "Continuous and categorical insomnia outcomes, derived from standard clinician- and self-rated assessments, were compared." | 2.70 | Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression. ( Borian, FE; Dunner, DL; Friedman, ES; Keller, MB; Klein, DN; Kornstein, SG; Manber, R; Markowitz, JC; Ninan, PT; Rush, AJ; Schatzberg, AF; Thase, ME; Trivedi, MH, 2002) |
| "Nefazodone was well tolerated, and no significant changes in sexual function were reported." | 2.69 | Open trial of nefazodone for combat-related posttraumatic stress disorder. ( Beckham, JC; Davidson, JR; Feldman, ME; Hertzberg, MA; Moore, SD, 1998) |
| " The rates for individual side effects with the serotonin selective reuptake inhibitors, nefazodone, and venlafaxine are presented and compared with the adverse event experience for mirtazapine." | 2.40 | Safety and tolerability of the new antidepressants. ( Nelson, JC, 1997) |
| "Therefore, early relief of insomnia in a depressed patient, in addition to alleviating other symptoms, may increase adherence to treatment and increase daytime performance and overall functioning, while complete relief of insomnia may improve prognosis." | 2.40 | Antidepressant treatment of the depressed patient with insomnia. ( Thase, ME, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (75.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brownlow, JA | 1 |
| Harb, GC | 1 |
| Ross, RJ | 1 |
| Wiegand, MH | 1 |
| Galanakis, P | 1 |
| Schreiner, R | 1 |
| Nelson, JC | 1 |
| Rickels, K | 1 |
| Schweizer, E | 1 |
| Case, WG | 1 |
| DeMartinis, N | 1 |
| Greenblatt, DJ | 1 |
| Mandos, LA | 1 |
| Garcia España, FG | 1 |
| Rush, AJ | 2 |
| Armitage, R | 1 |
| Gillin, JC | 1 |
| Yonkers, KA | 1 |
| Winokur, A | 1 |
| Moldofsky, H | 1 |
| Vogel, GW | 1 |
| Kaplita, SB | 1 |
| Fleming, JB | 1 |
| Montplaisir, J | 1 |
| Erman, MK | 1 |
| Albala, BJ | 1 |
| McQuade, RD | 1 |
| Hertzberg, MA | 1 |
| Feldman, ME | 1 |
| Beckham, JC | 1 |
| Moore, SD | 1 |
| Davidson, JR | 1 |
| Scharf, MB | 1 |
| McDannold, M | 1 |
| Zaretsky, N | 1 |
| Spinner, O | 1 |
| Stover, R | 1 |
| Berkowitz, DV | 1 |
| Conrad, C | 1 |
| Thase, ME | 2 |
| Manber, R | 1 |
| Kornstein, SG | 1 |
| Klein, DN | 1 |
| Markowitz, JC | 1 |
| Ninan, PT | 1 |
| Friedman, ES | 1 |
| Dunner, DL | 1 |
| Schatzberg, AF | 1 |
| Borian, FE | 1 |
| Trivedi, MH | 1 |
| Keller, MB | 1 |
3 reviews available for nefazodone and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
Treatment of Sleep Disturbances in Post-Traumatic Stress Disorder: A Review of the Literature.
Topics: Antipsychotic Agents; Cognitive Behavioral Therapy; Dreams; Eye Movement Desensitization Reprocessin | 2015 |
Safety and tolerability of the new antidepressants.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressiv | 1997 |
Antidepressant treatment of the depressed patient with insomnia.
Topics: Antidepressive Agents, Tricyclic; Comorbidity; Cyclohexanols; Depressive Disorder; Fluoxetine; Human | 1999 |
6 trials available for nefazodone and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
Nefazodone in primary insomnia: an open pilot study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Female; Humans; Male; Middle Aged; Patient Dr | 2004 |
Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzodiazepines; Depress | 1998 |
Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Circadian Rhythm; Comorbidity; Dep | 1998 |
Open trial of nefazodone for combat-related posttraumatic stress disorder.
Topics: Adult; Ambulatory Care; Anger; Antidepressive Agents, Second-Generation; Combat Disorders; Depressiv | 1998 |
Evaluation of sleep architecture and cyclic alternating pattern rates in depressed insomniac patients treated with nefazodone hydrochloride.
Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Male; Periodicity; Pipe | 1999 |
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Comb | 2002 |
3 other studies available for nefazodone and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
[Nefazodone: a new antidepressive agent. Advantages of a dual working principle].
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Piperazines; Sleep; Sleep Ini | 1997 |
[Sleep-profile of a 72-year-old depressive female patient. Depression and sleep disorders. Significance--causes--treatment].
Topics: Aged; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Piperazines; Sleep Initi | 1998 |
[Depression and sleep disorders. Progress in antidepressive therapy with nefazodone].
Topics: Antidepressive Agents, Second-Generation; Depression; Humans; Piperazines; Sleep Initiation and Main | 1998 |